Skip to main content
. 2021 Oct 28;12:705086. doi: 10.3389/fimmu.2021.705086

Figure 8.

Figure 8

PMEPA1 predicts the molecular subtype and the therapeutic response to several therapies in BLCA. (A) Correlations between PMEPA1 and molecular subtypes using seven different algorithms. (B) Correlations between PMEPA1 and bladder cancer signatures. (C) Correlations between PMEPA1 and the enrichment scores of several therapeutic signatures such as targeted therapy and radiotherapy. (D) The workflow of the rest of the work.